Tom Powles (@tompowles1) 's Twitter Profile
Tom Powles

@tompowles1

Interested in Urology Cancers, biomarkers and drug development.

ID: 1206580727296544769

calendar_today16-12-2019 14:24:22

1,1K Tweet

12,12K Followers

62 Following

Tom Powles (@tompowles1) 's Twitter Profile Photo
Tom Powles
@tompowles1

2 months ago

Longer follow up for Enfortumab Vedotin & Pembro in urothelial cancer Annals of Oncology shows mOS at nearly 3 yrs (34 mnths) with 50% of responses (68%) continuing at 2 years! Experience in tox management is important. Duration of therapy uncertain in CR gbr01.safelinks.protection.outlook.com/?url=https%3A%…

Longer follow up for Enfortumab Vedotin &amp; Pembro in urothelial cancer <a href="/Annals_Oncology/">Annals of Oncology</a> shows mOS at nearly 3 yrs (34 mnths) with 50% of responses (68%) continuing at 2 years! Experience in tox management is important. Duration of therapy uncertain in CR gbr01.safelinks.protection.outlook.com/?url=https%3A%…